The Impact of Rosuvastatin on the Density Score of Coronary Artery Calcification in CAD Patients With Diabetes Mellitus

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 122 participants.

Also called NCT02418884

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 122 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02418884
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02418884. Allocation not applicable; no masking; primary purpose prevention. Start 2015-04 (registry gives no type); primary completion 2018-03 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Impact of Rosuvastatin on the Density Score of Coronary Artery Calcification in CAD Patients With Diabetes Mellitus
Intervention (Drug)
rosuvastatin
Lead sponsor
Sir Run Run Shaw Hospital (class: other)

Record details

Record id
cardio:ct-nct02418884
Content hash
26476cd571b72ede2dc2ac6bb0aa61f6b4d775d430509dce12c23584cf51fad9